Evidence map›Paper›PMID 29481786›Full record

ArticleExperimental eye research2018

Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury.

Luciana Lassance, Gustavo K Marino, Carla S Medeiros, Shanmugapriya Thangavadivel, Steven E Wilson

Open access · bronzeAbstract read
In one paragraph

Article in Experimental eye research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Healed Perforated Corneal Ulcers in Human.Life (Basel, Switzerland) · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Luciana LassanceCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Gustavo K MarinoUniversity of Sao Paulo, Sao Paulo, Brazil.
Carla S MedeirosCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States; University of Sao Paulo, Sao Paulo, Brazil.
Shanmugapriya ThangavadivelCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States.
Steven E WilsonCole Eye Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: wilsons4@ccf.org.
Cleveland Clinic · USUniversidade de São Paulo · BR

Funding

RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI Brian D Perkins · 2016 to 2026
$7.7M
Corneal Epithelial Growth Factors and ReceptorsR01EY010056 · NEI · UNIVERSITY OF WASHINGTON · PI WILSON, STEVEN EUGENE · 1994 to 2020
$7.4M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY010056NEI NIH HHS T32 EY007157
6 · The paper itself

Abstract

The aim of this study was to determine whether bone marrow-derived fibrocytes migrate into the cornea after stromal scar-producing injury and differentiate into alpha-smooth muscle actin (αSMA) + myofibroblasts. Chimeric mice expressing green fluorescent protein (GFP) bone marrow cells had fibrosis (haze)-generating irregular phototherapeutic keratectomy (PTK). Multiplex immunohistochemistry (IHC) for GFP and fibrocyte markers (CD34, CD45, and vimentin) was used to detect fibrocyte infiltration into the corneal stroma and the development of GFP+ αSMA+ myofibroblasts. IHC for activated caspase-3, GFP and CD45 was used to detect fibrocyte and other hematopoietic cells undergoing apoptosis. Moderate haze developed in PTK-treated mouse corneas at 14 days after surgery and worsened, and persisted, at 21 days after surgery. GFP+ CD34+ CD45+ fibrocytes, likely in addition to other CD34+ and/or CD45+ hematopoietic and stem/progenitor cells, infiltrated the cornea and were present in the stroma in high numbers by one day after PTK. The fibrocytes and other bone marrow-derived cells progressively decreased at four days and seven days after surgery. At four days after PTK, 5% of the GFP+ cells expressed activated caspase-3. At 14 days after PTK, more than 50% of GFP+ CD45+ cells were also αSMA+ myofibroblasts. At 21 days after PTK, few GFP+ αSMA+ cells persisted in the stroma and more than 95% of those remaining expressed activated caspase-3, indicating they were undergoing apoptosis. GFP+ CD45+ SMA+ cells that developed from 4 to 21 days after irregular PTK were likely developed from fibrocytes. After irregular PTK in the strain of C57BL/6-C57/BL/6-Tg(UBC-GFP)30Scha/J chimeric mice, however, more than 95% of fibrocytes and other hematopoietic cells underwent apoptosis prior to the development of mature αSMA+ myofibroblasts. Most GFP+ CD45+ αSMA+ myofibroblasts that did develop subsequently underwent apoptosis-likely due to epithelial basement membrane regeneration and deprivation of epithelium-derived TGFβ requisite for myofibroblast survival.

Indexed as

ApoptosisActinsAnimalsBone Marrow CellsCaspase 3Cell DifferentiationCell MovementCollagen Type ICorneal InjuriesCorneal KeratocytesFemaleFibroblastsGreen Fluorescent ProteinsImmunohistochemistryMiceMice, Inbred C57BLActinsalpha-smooth muscle actin, mouseCasp3 protein, mouseCaspase 3Collagen Type IGreen Fluorescent ProteinsVimentinVim protein, mouseApoptosisCornea wound healingFibrocytesFibrosisHazeMyofibroblasts

Identifiers

PMID29481786
PMCPMC5924631
OpenAlexW2793037469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.